STAT January 26, 2023
Advisers to the Food and Drug Administration voted Thursday to back a plan whereby all Covid vaccines would move to the formulation used for the updated boosters, a step toward the goal of creating a single annual Covid shot for most Americans.
The panel said that a single vaccine would both be more effective and less confusing to both patients and health care workers.
The panel voted 21-to-0 to direct vaccine manufacturers Pfizer/BioNTech, Moderna, and Novavax to “harmonize” the primary series of their vaccines — the first doses that people receive — with the new booster shots that contain both the original strain of the SARS-CoV-2 virus and a new Omicron strain.
Members of the panel were also supportive of...
Today's Sponsors
Today's Sponsor